Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Japan's Kyowa Hakko Invests In Antibodies
July 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Japanese pharmaceutical company Kyowa Hakko Kogyo is to invest some US$27mn on a new GMP-compliant animal cell culture unit. The expansion to the Fuji manufacturing facility is expected to begin in early 2007, with the site coming onstream in early 2009. Company sources note that the purpose of the expansion is to boost development activity on antibodies for use in clinical